Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.59 |
| ▸ | CDK9 | P50750 | 1/20 | 0.59 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.59 |
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11319855 | 0.98 | EPHX1 (0.57) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL9461426 | 0.84 | POLB (0.49) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL11147820 | 0.83 | TGM2 (0.46) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL10936926 | 0.83 | EPHX1 (0.48) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL11152964 | 0.83 | BAZ1A (0.52) | EPHX2ALDH1A1LMNAHTTMEN1 | |
| SCHEMBL8937595 | 0.83 | MAOA (0.53) | EPHX1TP53TSHRALDH1A1KDM4E | |
| SCHEMBL10754360 | 0.83 | HDAC3 (0.59) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL10192071 | 0.82 | NPC1 (0.61) | SMN1; SMN2ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL11078164 | 0.82 | EPHX1 (0.59) | EPHX1TP53SMN1; SMN2TSHREPHX2 | |
| SCHEMBL7016073 | 0.82 | GAA (0.42) | EPHX1TP53SMN1; SMN2TSHREPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115627002-A | Formula, preparation method and application of epoxy prepreg | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2023-01-20 | — | — | CN | claimed |
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2009-06-25 | — | — | US | claimed |
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2004-10-28 | — | — | US | claimed |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2003-04-10 | — | — | US | claimed |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2001-11-01 | — | — | US | claimed |
| EP-0923537-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1999-06-23 | — | — | EP | claimed |
| WO-1998008805-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-03-05 | — | — | WO | claimed |
| CN-118344633-A | Preparation method of copper-free composite resin brake pad | 浙江万赛汽车零部件股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-115627002-A | Formula, preparation method and application of epoxy prepreg | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2023-01-20 | — | — | CN | disclosed |
| EP-3791724-A1 | TREATMENT OF BREAST CANCER | Medivation Prostate Therapeutics LLC (US) | 2021-03-17 | — | — | EP | disclosed |
| US-20210069154-A1 | Treatment of Breast Cancer | MEDIVATION PROSTATE THERAPEUTICS LLC | 2021-03-11 | — | — | US | disclosed |
| EP-3610731-A1 | TREATMENT OF BREAST CANCER | Medivation Prostate Therapeutics LLC (US) | 2020-02-19 | — | — | EP | disclosed |
| US-20190262315-A1 | Treatment of Breast Cancer | MEDIVATION PROSTATE THERAPEUTICS, INC. | 2019-08-29 | — | — | US | disclosed |
| EP-0216531-A1 | Use of immersion tin and tin alloys as a bonding medium for multilayer circuits | TECHNO INSTRUMENTS INVESTMENTS 1983 LTD. (IL) | 1987-04-01 | — | — | EP | disclosed |
| EP-0108570-B1 | DISAZO DYESTUFFS FOR CELLULOSE-CONTAINING FIBRES AND PROCESS FOR PREPARING THE DYESTUFF | MITSUBISHI KASEI CORPORATION (JP) | 1986-10-29 | — | — | EP | disclosed |
| EP-0121825-B1 | MONOAZO DYESTUFFS FOR CELLULOSE-CONTAINING FIBERS | MITSUBISHI KASEI CORPORATION (JP) | 1986-09-10 | — | — | EP | disclosed |
| US-4260552-A | INSECTICIDES, HERBICIDES | UNIROYAL, INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4160846-A | Method for controlling insects with tetrasubstituted organotin compounds | UNIROYAL, INC. (US) | 1979-07-10 | — | — | US | disclosed |
| US-4085268-A | Disubstituted s-triazines | ARMSTRONG CORK COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4010281-A | N-(4-HALOBENZYL)-N-BRANCHED ALKYL-N'-PHENYLUREAS AND FUNGICIDAL USE THEREOF | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, CHRM1, SRMS | EPHX1 2612/4885TP53 3031/4885SMN1; SMN2 1400/4885 |
| US-20190262315-A1 | Treatment of Breast Cancer | BRCA1, TP53, TUBB6 | EPHX1 3823/4885TP53 2/4885SMN1; SMN2 3361/4885 |
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | EPHX1 2441/4885TP53 3914/4885SMN1; SMN2 1689/4885 |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | SLC1A5, NEFM, SRMS | EPHX1 2183/4885TP53 4212/4885SMN1; SMN2 1673/4885 |
| US-20210069154-A1 | Treatment of Breast Cancer | BRCA1, TP53, TUBB6 | EPHX1 3823/4885TP53 2/4885SMN1; SMN2 3361/4885 |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | EPHX1 2441/4885TP53 3914/4885SMN1; SMN2 1689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.